Tran-Der Tan M.D.

Hematology and Medical Oncology
Medical Team: Lymphoma & Leukemia, Bone Marrow Transplantation

Current Title

  • Attending Physician, Division of Hematology and Medical Oncology, 1995-present
  • Director, Leukemia, Lymphoma, and Stem Cell Transplant Multidisciplinary Teams, 1995-present 

Specialties

  • Hematology
  • Bone marrow and peripheral blood stem cell transplantation

Clinical Interests

  • Chemotherapy on hematology and solid neoplasms
  • Hematopoietic disorders
  • Coagulation disorders

Languages Spoken

  • Mandarin Chinese
  • Taiwanese
  • English

Education and Training

1981-1988 Taipei Medical University, Taiwan, MD, Medicine
1988-1990 Medical Officer, Chinese Army
1990-1995  Residency & Fellowship, Taipei Veterans General Hospital, Taiwan

Professional Experience

1995-present Attending Physician, Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan
1995-present Director, Leukemia, Lymphoma, and Stem Cell Transplant Multidisciplinary Teams, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan

Professional Memberships

  • Member, Taiwan Internal Medicine Society
  • Member, Medical Oncology of the Chinese Oncology Society
  • Member, Hematology Society of Taiwan
  • Member, Taiwan Society of Blood and Marrow Transplantation

Selected Publications

  1. T.D. Tan, M.-C. Wu, J.L.W. Chiou Treatment of relapsed acute leukaemia patients after haematopoietic stem cell transplantation – a single-centre experience. Bone Marrow Transplantation Vol 45, Supplement 2, S418, Mar 2010.
  2. T.D. Tan, M.C. Wu, J.L.W. Chiou. Allogeneic haematopoietic stem cell transplantation for relapsed/refractory acute leukaemia – a single-centre experience. Bone Marrow Transplantation Vol 45, Supplement 2, S94~S95, Mar 2010.
  3. Wei-Ting Chen , Ting-Mei Liu, Shih-Hsuan Wu, Tran-Der Tan, Hsiu-Chin Tseng e, Chiang-Ching ShihImproving diagnosis of central venous catheter-related bloodstream infection by using differential time to positivity as a hospital-wide approach at a cancer hospital. Journal of Infection Vol 59 (5); p 317~323 Nov 2009
  4. Tran-Der Tan. Addition of Anti-Thymocyte Globulin Could Reduce the GVHD and not Increase Mortality in Unrelated Stem Cell Transplantation. Bone Marrow Transplantation Vol 43, Supplement 1, s140~141, March 2009.
  5. Tran-Der Tan. CMV Infection in Seropositive Patients with Haematologic Malignancies after Allogeneic Peripheral Blood Sem Cell Transplantation. Bone Marrow Transplantation Vol 43, Supplement 1, s369, March 2009.
  6. Tran-Der Tan, M. Lee. The shift of treatment for nasal and nasal-type NK/T cell lymphoma, ten years experience and prognostification analysis in a single institution. Haematologica 2007; 92(s1): p263.
  7. M. Lee, Tran-Der Tan. Clinicopathologic analysis of acute myeloid leukemia in a single institution: biphenotypic acute myeloid leukemia may not be an aggressive subtype. J Chin Med Assoc 2007(7): 269~273.
  8. M-Y. Lee, M-H Tsou, Tran-Der Tan, M-C Liu. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma. Eur J Haematol 2005; 75: 221~226.
  9. Ming-Yuan Lee, Tran-Der Tan, An-Chen Feng, and Mei-Ching Liu. Clinicopathological Analysis of 598 Malignant Lymphomas in Taiwan: Seven-Year Experience in a Single Institution. Am J Hematol 2006; 81: 568~575.
  10. Stella Y.C. Tsai, Tran-Der Tan, et al. Brain stem doses for patients of T3/T4 nasopharyngeal carcinoma treated by bid irradiation and concomitant chemotherapy. Therapeutic Radiology and Oncology 2005; 12(3): 167~180.
  11. S.H. Cheng, Tran-Der Tan et al. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. Int J Radiation Oncology Biol Phys 2005; 61(2): 456~465.
  12. S.H. Cheng, Tran-Der Tan et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J of Clin Oncol 2000; 18: 2040~2045.
  13. J C Cheng, Tran-Der Tan et al. Prophylactic para-aortic radiotherapy and concomitant chemotherapy for patients with cervical carcinoma: preliminaryt analysis of outcome and toxicity. Therapeutic Radiology and Oncology 2000; 7(4): 243~251.
  14. Mei-Hua Tsou, Tran-Der Tan et al. Case report small cell carcinoma of the uterine cervix with large cell neuroendocrine carcinoma component. Gynecologic Oncology 1998; 68: 69~72.
  15. S.H. Cheng, Tran-Der Tan et al. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiation Oncology Biolo Phys 1998; 41(4): 755~762.
  16. T.D. Tan, M.-C. Wu, J.L.W. Chiou  Long-term survival of mantle cell lymphoma – A single institution experience in Taiwan. Haematologica 2010; 95(s2) p633 (Abstract 1607).
  17. T.D. Tan, M.-C. Wu, J.L.W. Chiou  Micafungin prophylaxis in hematopoietic stem cell transplantation – A single institution experience.  Haematologica 2010; 95(s2) p728~729 (Abstract 1889).
  18. T.D. Tan, M.-C. Wu, J.L.W. Chiou Treatment of relapsed acute leukaemia patients after haematopoietic stem cell transplantation – a single-centre experience. Bone Marrow Transplantation Vol 45, Supplement 2, S418, Mar 2010.
  19. T.D. Tan, M.C. Wu, J.L.W. Chiou. Allogeneic haematopoietic stem cell transplantation for relapsed/refractory acute leukaemia – a single-centre experience. Bone Marrow Transplantation Vol 45, Supplement 2, S94~S95, Mar 2010.
  20. L.H.Fang, C.J.Huang, T.D.Tan, et al. Chemotherapy-related delayed bilateral spontaneous pneumothorax and lung fibrosis: methotrexate or cyclophosphamide, or both? Clinical Respiratory Journal 2010 p254~255.
  21. Wei-Ting Chen , Ting-Mei Liu, Shih-Hsuan Wu, Tran-Der Tan, Hsiu-Chin Tseng e, Chiang-Ching ShihImproving diagnosis of central venous catheter-related bloodstream infection by using differential time to positivity as a hospital-wide approach at a cancer hospital. Journal of Infection Vol 59 (5); p 317~323 Nov 2009.

Abstracts/Presentations:

  1. Allogeneic haematopoietic stem cell transplantation for relapsed/refractory acute leukaemia – a single-centre experience.EBMT 2010. (Poster presentation)
  2. Velcade Combination Chemotherapy and reduced intensity allogeneic stem cell transplantation for the Treatment of Relapsed Mantle Cell Lymphoma. (Oral Presentation) 2010 Annual Meeting of Chinese Hematology Society.
  3. ASH Update in CML New TKI Therapy. Taiwan Hematology Meeting Jan 31 2010.
  4. Tasigna Clinical Data Update Taiwan Hematology Meeting Jan 30 2010.
  5. Long-term Survival of Mantle Cell Lymphoma – A Single Institution Experience. Oral presentation at VGH-Taipei Meeting. Mar 10 2010.
  6. Addition of Anti-Thymocyte Globulin Could Reduce the GVHD and not Increase Mortality in Unrelated Stem Cell Transplantation. Goteborg, EBMT 2009. (Poster presentation)
  7. Treatment Algorithm of Relapsed Leukemia after Hematopoietic Stem Cell Transplantation.  2009 Annual Meeting of Asia-Pacific Blood and Marrow Transplantation, Seoul, South Korea (Poster presentation).
  8. Micafungin Prophylaxis in Hematopoietic Stem Cell Transplant  2009 Annual Meeting of Asia-Pacific Blood and Marrow Transplantation, Seoul, South Korea (Poster presentation).
  9. Treatment of Relapsed Acute Leukemia after Hematopoietic Stem Cell Transplantation. (Oral Presentation) 2009 Annual Meeting of Chinese Hematology Society.
  10. The Shift of Treatment for Nasal and Nasal-type NK/T cell lymphoma, ten years experience and prognostification analysis in a single institution. 2007 Annual Meeting of European Haematology Association. (Poster presentation)
  11. Cytomegalovirus Infection of Post-Hematopoetic Stem Cell Transplant  in Seropositive Population.  2008 Annual Meeting of Asia-Pacific Blood and Marrow Transplantation, Taipei.
  12. TBI 2Gy and Fludarabine as the Nonmyeloablative conditioning in relapsed lymphoma – A single institute experience.  Hong-Kang, Annual Meeting of HKSH 2009 and CBMT Forum (poster presentation).
  13. Non-myeloablative allogeneic peripheral blood stem cell transplantation for relapsed lymphoma—A single institute experience. 2008 Seasonal Meeting of Chinese Hematology Society..
  14. Comparative Outcomes between Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation – the experience from a single institute. 2008 Annual Meeting of Chinese Hematology Society.
  15. The Shift of Treatment for Nasal and Nasal-type NK/T cell lymphoma. 2007 Annual Meeting of Chinese Hematology Society.
  16. Treatment of Mantle cell lymphoma. 2006 Annual Meeting of Chinese Internal Medicine Society Satellite Meeting.
  17. Failure Pattern of Stem Cell Transplant  2006 Annual Meeting of Chinese Hematology Society.
  18. The temporal change of hemoglobin, Anti-A and Anti-B titers, and the necessity of packed cell transfusions before and after the treatment of Rituximab. 2005 Annual Meeting of Chinese Hematology Society.
  19. Pulmonary complication in stem cell transplantation. 2005 Annual Meeting of Chinese Hematology Society.
  20. Medical Treatment of Metastatic Cancer to the Bone. 2005 Annual Meeting of Chinese Orthopaedic Society.
  21. Treatment of Peripheral T Cell Lymphoma. 2004 Annual Meeting of Chinese Hematology Society.
  22. Case report-Prostate lymphoma with intravascular lymphomatosis. 2003 Annual Meeting of Chinese Hematology Society.
  23. Long-term survival of mantle cell lymphoma – A single institution experience in Taiwan. European Haematology Association 2010 Annual Meeting, Barcelona, Spain.
  24. Micafungin prophylaxis in hematopoietic stem cell transplantation – A single institution experience. European Haematology Association 2010 Annual Meeting, Barcelona, Spain.
  25. Allogeneic haematopoietic stem cell transplantation for relapsed/refractory acute leukaemia – a single-centre experience.EBMT 2010. (Poster presentation)
  26. Velcade Combination Chemotherapy and reduced intensity allogeneic stem cell transplantation for the Treatment of Relapsed Mantle Cell Lymphoma. (Oral Presentation) 2010 Annual Meeting of Chinese Hematology Society.
  27. Salvage Treatment for Relapsed Mantle Cell Lymphoma. Asia-Pacific Bone Marrow Transplantation 2010 Annual Meeting, Phuket, Tailand.
  28. Hematolpoietic Stem Cell Transplant versus Chemotherapy for multiple myeloma. Asia-Pacific Bone Marrow Transplantation 2010 Annual Meeting, Phuket, Tailand.
  29. Stem Cell Transplantation for Multiple Myeloma. Seasonal Meeting of Taiwan Hematology Association. Tainan, 14/Aug/14.
  30. Frontline and Salvage Treatment of Multiple Myelom. Seasonal Meeting of Southern Taiwan Hematology Association, Ping-Tong, 28/Aug/2010.
  31. Overview of Iron Threat for BMT patients. Seasonal Meeting of Northern Taiwan BMT Association, Taipei, 10/Sep/2010.
  32. Clinical cases of Nilotinib treatment for imatinib failure CML patients. CML Summit. Taipei. 30/May/2010.
  33. Current Status and Clinical Challenges for Treatment of CML in Taiwan. CML Summit. Taipei 20/Nov/2010.     
  34. ASH Update in CML New TKI Therapy. Taiwan Hematology Meeting Jan 31 2010.
  35. Tasigna Clinical Data Update Taiwan Hematology Meeting Jan 30 2010.
  36. Long-term Survival of Mantle Cell Lymphoma – A Single Institution Experience. Oral presentation at VGH-Taipei Meeting. Mar 10 2010.

Invited Speaker:

  1. Treatment of Thymoma
  2. Engraftment Syndrome following Hematopoietic Stem Cell Transplantation
  3. A Prostate Lymphoma Patient Died of Intravascular Lymphomatosis Associated with Microangiopathy
  4. Intensive Neoadjuvant and Adjuvant Chemotherapy and Limb-Preserving Surgery to Treat High Grade Bone Tumor
  5. Treatment of Neutropenic fever in cancer patients
  6. Evolving Therapeutic Strategies of Acute Promyelocytic Leukemia
  7. Current Treatment of Non-Hodgkin Lymphoma
  8. One-year Experience of Hematopoietic Peripheral Blood Stem Cell Transplantation

Principle Investigator of Clinical Trials:

  1. Hematopoietic stem cell transplantation.
  2. Treatment of leukemia, lymphoma, and multiple myeloma.
  3. Treatment of osteosarcoma.
  4. Treatment of urologic cancers including germ cell cancer.
TOP
Copyright © Koo Foundation Sun Yat-Sen Cancer Center 125 Lih-Der Road, Pei-Tou District, Taipei, Taiwan. Tel:+886 2 2897-0011